MARKET INTRODUCTION
Potassium gluconate is mineral drug therapy generally given in patients with lower potassium levels in their blood stream which is referred to as hypokalemia. Low potassium levels leads to abnormal body functions. Potassium gluconate regulates proper functioning of cells, kidney, muscles, nervous system etc. Low potassium levels in person can lead to fatigue, abnormal nerve functioning and weakness so in such cases potassium gluconate is given for treating such condition.
MARKET DYNAMICS
The key market drivers for Potassium Gluconate Market Includes, increasing prevalence of chronic diseases such as kidney failure, edema, UTIs along with rising geriatric population. Moreover, rising awareness about healthy lifestyle is also expected to boost market growth during the forecast period. Whereas, stringent regulatory policies and approval procedures for pharmaceutical products is expected to hinder market growth during the forecast period.
MARKET SCOPE
The "Potassium Gluconate Market" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Potassium Gluconate market with detailed market segmentation by dosage form and end user. The Potassium Gluconate Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Potassium Gluconate Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Potassium Gluconate Market is segmented on the basis of dosage form and end user. On the basis of dosage form the market is segmented as, oral and parenteral. And on the basis of end user the market is segmented as, hospitals, clinics and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Potassium Gluconate Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Potassium Gluconate Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Potassium Gluconate Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Potassium Gluconate Market in these regions.
MARKET PLAYERS
The report covers key developments in the Potassium Gluconate Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Potassium Gluconate Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Potassium Gluconate market in the global market. Below mentioned is the list of few companies engaged in the Potassium Gluconate Market.
The report also includes the profiles of key players in Potassium Gluconate Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Novartis AG
- GlaxoSmithKline Plc
- Merck and Co., Inc
- Abbott Laboratories
- Boehringer Ingelheim GmbH
- AstraZeneca Plc
- F. Hoffmann-La Roche AG
- Teva Pharmaceutical Industries Ltd
- Vectura Group plc
- Pfizer Inc
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Potassium Gluconate Market - By Dosage Form
1.3.2 Potassium Gluconate Market - By End User
1.3.3 Potassium Gluconate Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. POTASSIUM GLUCONATE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. POTASSIUM GLUCONATE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. POTASSIUM GLUCONATE MARKET - GLOBAL MARKET ANALYSIS
6.1. POTASSIUM GLUCONATE - GLOBAL MARKET OVERVIEW
6.2. POTASSIUM GLUCONATE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. POTASSIUM GLUCONATE MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM
7.1. OVERVIEW
7.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
7.3. ORAL
7.3.1. Overview
7.3.2. Oral Market Forecast and Analysis
7.4. PARENTERAL
7.4.1. Overview
7.4.2. Parenteral Market Forecast and Analysis
8. POTASSIUM GLUCONATE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. POTASSIUM GLUCONATE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Potassium Gluconate Market Overview
9.1.2 North America Potassium Gluconate Market Forecasts and Analysis
9.1.3 North America Potassium Gluconate Market Forecasts and Analysis - By Dosage Form
9.1.4 North America Potassium Gluconate Market Forecasts and Analysis - By End User
9.1.5 North America Potassium Gluconate Market Forecasts and Analysis - By Countries
9.1.5.1 United States Potassium Gluconate Market
9.1.5.1.1 United States Potassium Gluconate Market by Dosage Form
9.1.5.1.2 United States Potassium Gluconate Market by End User
9.1.5.2 Canada Potassium Gluconate Market
9.1.5.2.1 Canada Potassium Gluconate Market by Dosage Form
9.1.5.2.2 Canada Potassium Gluconate Market by End User
9.1.5.3 Mexico Potassium Gluconate Market
9.1.5.3.1 Mexico Potassium Gluconate Market by Dosage Form
9.1.5.3.2 Mexico Potassium Gluconate Market by End User
9.2. EUROPE
9.2.1 Europe Potassium Gluconate Market Overview
9.2.2 Europe Potassium Gluconate Market Forecasts and Analysis
9.2.3 Europe Potassium Gluconate Market Forecasts and Analysis - By Dosage Form
9.2.4 Europe Potassium Gluconate Market Forecasts and Analysis - By End User
9.2.5 Europe Potassium Gluconate Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Potassium Gluconate Market
9.2.5.1.1 Germany Potassium Gluconate Market by Dosage Form
9.2.5.1.2 Germany Potassium Gluconate Market by End User
9.2.5.2 France Potassium Gluconate Market
9.2.5.2.1 France Potassium Gluconate Market by Dosage Form
9.2.5.2.2 France Potassium Gluconate Market by End User
9.2.5.3 Italy Potassium Gluconate Market
9.2.5.3.1 Italy Potassium Gluconate Market by Dosage Form
9.2.5.3.2 Italy Potassium Gluconate Market by End User
9.2.5.4 Spain Potassium Gluconate Market
9.2.5.4.1 Spain Potassium Gluconate Market by Dosage Form
9.2.5.4.2 Spain Potassium Gluconate Market by End User
9.2.5.5 United Kingdom Potassium Gluconate Market
9.2.5.5.1 United Kingdom Potassium Gluconate Market by Dosage Form
9.2.5.5.2 United Kingdom Potassium Gluconate Market by End User
9.2.5.6 Rest of Europe Potassium Gluconate Market
9.2.5.6.1 Rest of Europe Potassium Gluconate Market by Dosage Form
9.2.5.6.2 Rest of Europe Potassium Gluconate Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Potassium Gluconate Market Overview
9.3.2 Asia-Pacific Potassium Gluconate Market Forecasts and Analysis
9.3.3 Asia-Pacific Potassium Gluconate Market Forecasts and Analysis - By Dosage Form
9.3.4 Asia-Pacific Potassium Gluconate Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Potassium Gluconate Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Potassium Gluconate Market
9.3.5.1.1 Australia Potassium Gluconate Market by Dosage Form
9.3.5.1.2 Australia Potassium Gluconate Market by End User
9.3.5.2 China Potassium Gluconate Market
9.3.5.2.1 China Potassium Gluconate Market by Dosage Form
9.3.5.2.2 China Potassium Gluconate Market by End User
9.3.5.3 India Potassium Gluconate Market
9.3.5.3.1 India Potassium Gluconate Market by Dosage Form
9.3.5.3.2 India Potassium Gluconate Market by End User
9.3.5.4 Japan Potassium Gluconate Market
9.3.5.4.1 Japan Potassium Gluconate Market by Dosage Form
9.3.5.4.2 Japan Potassium Gluconate Market by End User
9.3.5.5 South Korea Potassium Gluconate Market
9.3.5.5.1 South Korea Potassium Gluconate Market by Dosage Form
9.3.5.5.2 South Korea Potassium Gluconate Market by End User
9.3.5.6 Rest of Asia-Pacific Potassium Gluconate Market
9.3.5.6.1 Rest of Asia-Pacific Potassium Gluconate Market by Dosage Form
9.3.5.6.2 Rest of Asia-Pacific Potassium Gluconate Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Potassium Gluconate Market Overview
9.4.2 Middle East and Africa Potassium Gluconate Market Forecasts and Analysis
9.4.3 Middle East and Africa Potassium Gluconate Market Forecasts and Analysis - By Dosage Form
9.4.4 Middle East and Africa Potassium Gluconate Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Potassium Gluconate Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Potassium Gluconate Market
9.4.5.1.1 South Africa Potassium Gluconate Market by Dosage Form
9.4.5.1.2 South Africa Potassium Gluconate Market by End User
9.4.5.2 Saudi Arabia Potassium Gluconate Market
9.4.5.2.1 Saudi Arabia Potassium Gluconate Market by Dosage Form
9.4.5.2.2 Saudi Arabia Potassium Gluconate Market by End User
9.4.5.3 U.A.E Potassium Gluconate Market
9.4.5.3.1 U.A.E Potassium Gluconate Market by Dosage Form
9.4.5.3.2 U.A.E Potassium Gluconate Market by End User
9.4.5.4 Rest of Middle East and Africa Potassium Gluconate Market
9.4.5.4.1 Rest of Middle East and Africa Potassium Gluconate Market by Dosage Form
9.4.5.4.2 Rest of Middle East and Africa Potassium Gluconate Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Potassium Gluconate Market Overview
9.5.2 South and Central America Potassium Gluconate Market Forecasts and Analysis
9.5.3 South and Central America Potassium Gluconate Market Forecasts and Analysis - By Dosage Form
9.5.4 South and Central America Potassium Gluconate Market Forecasts and Analysis - By End User
9.5.5 South and Central America Potassium Gluconate Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Potassium Gluconate Market
9.5.5.1.1 Brazil Potassium Gluconate Market by Dosage Form
9.5.5.1.2 Brazil Potassium Gluconate Market by End User
9.5.5.2 Argentina Potassium Gluconate Market
9.5.5.2.1 Argentina Potassium Gluconate Market by Dosage Form
9.5.5.2.2 Argentina Potassium Gluconate Market by End User
9.5.5.3 Rest of South and Central America Potassium Gluconate Market
9.5.5.3.1 Rest of South and Central America Potassium Gluconate Market by Dosage Form
9.5.5.3.2 Rest of South and Central America Potassium Gluconate Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. POTASSIUM GLUCONATE MARKET, KEY COMPANY PROFILES
11.1. NOVARTIS AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GLAXOSMITHKLINE PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK AND CO., INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ABBOTT LABORATORIES
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BOEHRINGER INGELHEIM GMBH
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ASTRAZENECA PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. F. HOFFMANN-LA ROCHE AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. VECTURA GROUP PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PFIZER INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Novartis AG
2. GlaxoSmithKline plc
3. Merck and Co., Inc
4. Abbott Laboratories
5. Boehringer Ingelheim GmbH
6. AstraZeneca plc
7. F. Hoffmann-La Roche AG
8. Teva Pharmaceutical Industries Ltd.
9. Vectura Group plc
10. Pfizer Inc.
Global Rare Hematology Market Growth Sta..
According to this study, over the next five years the Rare H..
+1-646-791 7070US (Toll Free)